20.65
3.28%
-0.70
Fulgent Genetics Inc stock is currently priced at $20.65, with a 24-hour trading volume of 174.47K.
It has seen a -3.28% decreased in the last 24 hours and a +1.47% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $21.22 pivot point. If it approaches the $20.44 support level, significant changes may occur.
Previous Close:
$21.35
Open:
$21.36
24h Volume:
174.47K
Market Cap:
$617.94M
Revenue:
$287.53M
Net Income/Loss:
$-165.95M
P/E Ratio:
-12.59
EPS:
-1.64
Net Cash Flow:
$17.95M
1W Performance:
-3.46%
1M Performance:
+1.47%
6M Performance:
-25.13%
1Y Performance:
-48.08%
Fulgent Genetics Inc Stock (FLGT) Company Profile
Name
Fulgent Genetics Inc
Sector
Industry
Phone
626-350-0537
Address
4978 Santa Anita Avenue, Temple City
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-07-23 | Initiated | UBS | Neutral |
Dec-08-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Nov-18-22 | Initiated | Raymond James | Outperform |
Aug-25-22 | Initiated | Credit Suisse | Outperform |
Feb-04-22 | Resumed | Piper Sandler | Overweight |
Aug-05-21 | Resumed | Credit Suisse | Underperform |
Jan-08-21 | Downgrade | Credit Suisse | Neutral → Underperform |
Nov-24-20 | Downgrade | BTIG Research | Buy → Neutral |
Aug-20-20 | Initiated | Oppenheimer | Outperform |
May-29-20 | Initiated | BTIG Research | Buy |
Nov-05-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
Mar-01-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
Nov-07-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Fulgent Genetics Inc Stock (FLGT) Latest News
Principal Financial Group Inc. Lowers Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Defense World
Dimensional Fund Advisors LP Acquires 147,505 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
MarketBeat
Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Path To Profitability - Yahoo Movies UK
Yahoo Movies UK
Dimensional Fund Advisors LP Boosts Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Defense World
Swiss National Bank Sells 4100 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Defense World
Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Path To Profitability - Yahoo Movies UK
Yahoo Movies UK
Fulgent Genetics Inc Stock (FLGT) Financials Data
Fulgent Genetics Inc (FLGT) Revenue 2024
FLGT reported a revenue (TTM) of $287.53 million for the quarter ending March 31, 2024, a -21.20% decline year-over-year.
Fulgent Genetics Inc (FLGT) Net Income 2024
FLGT net income (TTM) was -$165.95 million for the quarter ending March 31, 2024, a -540.33% decrease year-over-year.
Fulgent Genetics Inc (FLGT) Cash Flow 2024
FLGT recorded a free cash flow (TTM) of $17.95 million for the quarter ending March 31, 2024, a -43.48% decrease year-over-year.
Fulgent Genetics Inc (FLGT) Earnings per Share 2024
FLGT earnings per share (TTM) was -$5.57 for the quarter ending March 31, 2024, a -525.84% decline year-over-year.
About Fulgent Genetics Inc
Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It markets its tests through internal sales force, as well as through independent sales representatives in the United States, Canada, the People's Republic of China, and internationally. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Cap:
|
Volume (24h):